Cancer Research Cell Death Mechanisms and Cancer Therapy  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrière, V.
Right arrow Articles by M'Rini, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrière, V.
Right arrow Articles by M'Rini, C.
[Cancer Research 65, 11639-11648, December 15, 2005]
© 2005 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

Cancer Cells Regulate Lymphocyte Recruitment and Leukocyte-Endothelium Interactions in the Tumor-Draining Lymph Node

Virginie Carrière1, Renaud Colisson1, Carine Jiguet-Jiglaire1, Elisabeth Bellard1, Gérard Bouche1, Talal Al Saati2, François Amalric1, Jean-Philippe Girard1 and Christine M'Rini1,3

1 Laboratoire de Biologie Vasculaire, Equipe labellisée "La Ligue 2003", Institut de Pharmacologie et de Biologie Structurale, CNRS UMR 5089; 2 Plateau Technique d'Histopathologie Expérimentale IFR30, CHU Purpan; and 3 Laboratoire de Physiologie, Faculté de Médecine de Rangueil, Toulouse, France

Requests for reprints: Christine M'Rini, Laboratoire de Biologie Vasculaire, Equipe labellisée "La Ligue 2003", Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique UMR 5089, 205 route de Narbonne, 31077 Toulouse, France. Phone: 33-5-6117-5537; Fax: 33-5-6117-5994; E-mail: mrini{at}ipbs.fr.

The physiologic function of the secondary lymphoid organs to recruit large numbers of naïve lymphocytes increases the probability that antigens encounter their rare, sometimes unique, specific T lymphocytes and initiate a specific immune response. In peripheral lymph nodes (LNs), this recruitment is a multistep process, initiated predominantly within the high endothelial venules (HEVs), beginning with rolling and chemokine-dependent firm adhesion of the lymphocytes on the venular endothelium surface. We report here that, in C57BL/6 mice, the recruitment of naïve lymphocytes is impaired in LNs draining a B16 melanoma tumor. Intravital microscopy analysis of the tumor-draining LNs revealed that this effect is associated with an important defect in lymphocyte adhesion in the HEVs and a progressive decrease in the expression of the LN chemokine CCL21. In parallel with these effects, the tumor up-regulated, essentially through a P-selectin–dependent mechanism, the rolling and sticking of circulating polymorphonuclear cells within the LN low-order venules where few rolling and sticking events are usually observed. These effects of the tumor were independent of the presence of metastasis into the LN and occurred as long as the tumor developed. Together, these results indicate that the tumor proximity disturbs the LN physiology by modifying the molecular, spatial, and cellular rules that usually control leukocyte-endothelium interactions into the peripheral LNs. In addition, they emphasize a new role for the low-order venules of the peripheral LNs, which compared with the HEVs, seem to be the preferential port of entry for cells linked to inflammatory processes. (Cancer Res 2005; 65(24): 11639-48)




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. M. Hanson, V. K. Clements, P. Sinha, D. Ilkovitch, and S. Ostrand-Rosenberg
Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
J. Immunol., July 15, 2009; 183(2): 937 - 944.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Flaishon, G. Hart, E. Zelman, C. Moussion, V. Grabovsky, G. Lapidot Tal, S. Feigelson, R. Margalit, A. Harmelin, T. Avin-Wittenberg, et al.
Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions
Blood, December 15, 2008; 112(13): 5016 - 5025.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. I. Harrell, B. M. Iritani, and A. Ruddell
Tumor-Induced Sentinel Lymph Node Lymphangiogenesis and Increased Lymph Flow Precede Melanoma Metastasis
Am. J. Pathol., February 1, 2007; 170(2): 774 - 786.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.